205 related articles for article (PubMed ID: 3947110)
21. Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons.
Brunda MJ; Rosenbaum D
Cancer Res; 1984 Feb; 44(2):597-601. PubMed ID: 6692364
[TBL] [Abstract][Full Text] [Related]
22. Human natural killer cells limit replication of herpes simplex virus type 1 in vitro.
Fitzgerald PA; Mendelsohn M; Lopez C
J Immunol; 1985 Apr; 134(4):2666-72. PubMed ID: 2982949
[TBL] [Abstract][Full Text] [Related]
23. Role of natural killer cells in the mechanism of the antitumor effect of interferon on Moloney sarcoma virus-transformed cells.
Fresa KL; Murasko DM
Cancer Res; 1986 Jan; 46(1):81-8. PubMed ID: 3940213
[TBL] [Abstract][Full Text] [Related]
24. The different effects of recombinant human interferon-gamma and recombinant human interferon-beta on the activation of natural killer cells.
Okabe M; Gomi K; Morimoto M; Nakamizo N
Jpn J Cancer Res; 1985 Jul; 76(7):608-17. PubMed ID: 3928557
[TBL] [Abstract][Full Text] [Related]
25. Suppressive effect of human natural killer cells on Epstein-Barr virus-induced immunoglobulin synthesis.
Kuwano K; Arai S; Munakata T; Tomita Y; Yoshitake Y; Kumagai K
J Immunol; 1986 Sep; 137(5):1462-8. PubMed ID: 3018077
[TBL] [Abstract][Full Text] [Related]
26. Relationship between natural killer (NK) cells and interferon (IFN) alpha-producing cells in human peripheral blood. Studies with a monoclonal antibody with specificity for human natural killer cells.
Abb J; Abb H; Deinhardt F
Immunobiology; 1984 Oct; 167(4):359-64. PubMed ID: 6510947
[TBL] [Abstract][Full Text] [Related]
27. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
Suthanthiran M; Williams PS; Solomon SD; Rubin AL; Stenzel KH
J Clin Invest; 1984 Dec; 74(6):2263-71. PubMed ID: 6392343
[TBL] [Abstract][Full Text] [Related]
28. Comparison of augmentation of human natural killer cell cytotoxicity by interferon-alpha subtypes.
Verhagen A; Mackay IR; Rowley M; Tymms M
Nat Immun Cell Growth Regul; 1990; 9(5):325-33. PubMed ID: 2077397
[TBL] [Abstract][Full Text] [Related]
29. [Studies on the antitumor activity of human recombinant interferon alpha-2b in vitro].
Haraguchi S; Koide Y; Matsuo T; Yoshida TO
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3236-43. PubMed ID: 2946265
[TBL] [Abstract][Full Text] [Related]
30. Systemic administration of human leukocyte interferon to melanoma patients. II. Cellular events associated with changes in natural killer cytotoxicity.
Golub SH; D'Amore P; Rainey M
J Natl Cancer Inst; 1982 May; 68(5):711-7. PubMed ID: 6175788
[TBL] [Abstract][Full Text] [Related]
31. Depletion of NK cells with the lysosomotropic agent L-leucine methyl ester and the in vitro generation of NK activity from NK precursor cells.
Shau H; Golub SH
J Immunol; 1985 Feb; 134(2):1136-41. PubMed ID: 3871208
[TBL] [Abstract][Full Text] [Related]
32. Phorbol ester-induced lymphocyte adherence: selective action on NK cells.
Argov S; Hebdon M; Cuatrecasas P; Koren HS
J Immunol; 1985 Apr; 134(4):2215-22. PubMed ID: 3855930
[TBL] [Abstract][Full Text] [Related]
33. Natural killer cell inhibition of young spherules and endospores of Coccidioides immitis.
Petkus AF; Baum LL
J Immunol; 1987 Nov; 139(9):3107-11. PubMed ID: 2444651
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of susceptibility of HSV-1-infected cells to natural killer lysis by interferon.
Muñoz A; Carrasco L; Fresno M
J Immunol; 1983 Aug; 131(2):783-7. PubMed ID: 6190939
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
Gan X; Zhang L; Solomon GF; Bonavida B
Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
[TBL] [Abstract][Full Text] [Related]
36. Role of interferon in human natural killer activity against target cells infected with HSV-1.
Bishop GA; Glorioso JC; Schwartz SA
J Immunol; 1983 Oct; 131(4):1849-53. PubMed ID: 6194217
[TBL] [Abstract][Full Text] [Related]
37. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
[TBL] [Abstract][Full Text] [Related]
38. Human peripheral blood monocytes are susceptible to interferon-activated natural killer cells.
Einhorn S; Anderbring E
J Clin Lab Immunol; 1985 Apr; 16(4):197-9. PubMed ID: 4020850
[TBL] [Abstract][Full Text] [Related]
39. Modulation of natural killing activity by lymphoblastoid interferon in cancer patients.
Koren HS; Brandt CP; Tso CY; Laszlo J
J Biol Response Mod; 1983; 2(2):151-65. PubMed ID: 6644332
[TBL] [Abstract][Full Text] [Related]
40. In vitro evaluation of 6-thioguanine and alpha-interferon as a therapeutic combination in HL-60 and natural killer cells.
Tan YY; Epstein LB; Armstrong RD
Cancer Res; 1989 Aug; 49(16):4431-4. PubMed ID: 2743331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
